HONG KONG – On the face of it, the idea of overseas-traded Chinese life science companies delisting from the US equity market to return home and eventually list on domestic exchanges is a “no-brainer”
Company Changes AUGUSTI , Mark To: Integra LifeSciences Holdings Corp. , Corp. VP, Orthopedics & Tissue Technologies (April) From: Bioventus LLC, CEO Phone: 609-275-0050 BORNHEIMER , Jimmy To
Company Changes AUGUSTI , Mark To: Integra LifeSciences Holdings Corp. , Corp. VP, Orthopedics & Tissue Technologies (April) From: Bioventus LLC, CEO Phone: 609-275-0050 BIERLY , Rick To: M